首页> 外国专利> Binding, which includes a single anti-IgF1R antigen or part of its antigen, is associated with leucocyte and 5-fluoride cyanide, leucocyte or optional unitinib, with another chemotherapist; and Colorec, which is used to treat or prevent cancer. Now I see

Binding, which includes a single anti-IgF1R antigen or part of its antigen, is associated with leucocyte and 5-fluoride cyanide, leucocyte or optional unitinib, with another chemotherapist; and Colorec, which is used to treat or prevent cancer. Now I see

机译:结合,包括单个抗IgF1R抗原或其部分抗原,与白细胞和5-氟氰化物,白细胞或可选的unitinib,与另一种化学治疗剂相关;和Colorec,用于治疗或预防癌症。现在我明白了

摘要

Combination comprising an isolated anti IGF1R Antibody or a fragment of fixing the same Antigen in association with leucovorin and 5-fluorouracilLeucovorin or sunitinib optionally associated with another chemotherapeutic Agent and its use for the Treatment or prevention of Colorectal Cancer.
机译:包含分离的抗IGF1R抗体或固定相同抗原的片段与亚叶酸和5-氟尿嘧啶叶绿素或舒尼替尼的组合,其任选地与另一种化学治疗剂结合的组合及其在治疗或预防结直肠癌中的用途。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号